Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GOLGA4 antisense RNA 1 (GOLGA4-AS1) is a long non-coding antisense RNA transcript located in the human genome. It is transcribed on the opposite strand of the GOLGA4 gene locus and is classified as a non-protein-coding RNA. Like other antisense RNAs, its principal molecular function is likely to be the post-transcriptional regulation of its sense partner gene, GOLGA4, possibly through mechanisms such as RNA-RNA interactions that affect mRNA stability or translation. To date, there are no specific drugs, known mechanisms of action for pharmacological targeting, or established clinical biomarker roles for GOLGA4-AS1. There is also no evidence that it directly serves as a therapeutic target, nor are there notable safety concerns documented in the scientific literature[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GOLGA4 antisense RNA 1 (GOLGA4-AS1).